Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Novus Medical Detox Comments on Emerging Big Pharma Marketing Trend—Study Says Pharmaceutical Companies Attempt to Sway Consumers with “Brand Personality” Marketing
  • USA - English


News provided by

JoTo PR

Apr 30, 2014, 09:00 ET

Share this article

Share toX

Share this article

Share toX


We’ve yet to gain control of prescription substance abuse within the U.S.—in fact, RX substance abuse is arguably at its worst point in years.

Post this

New Port Richey, FL (PRWEB) April 30, 2014 -- Millions of citizens have secured health insurance under the Affordable Care Act (ACA)—that, coupled with the public’s growing distrust of drug companies, is forcing a radical transformation of pharmaceutical branding (1). Studies have shown that by imbuing their brands with human characteristics, pharmaceutical companies can boost sales by developing direct relationships with their consumers, and as a result, patients are more likely to ask their physicians to prescribe specific brand-name medications (2). This emerging trend has prompted Novus Medical Detox, one of the only Florida-based detox centers serving high-dosage prescription drug abuse patients, to advise the public against allowing marketing trends to influence their reliance on prescription drugs. Novus officials suggest that consumers refrain from relying primarily on pharmaceutical companies for their health information, but rather to seek unbiased medical reports via credible sources.

Last year, only 56 percent of consumers said they trusted the drug companies—a likely motive for drugmakers transitioning from “pushing pills” to insinuating their corporate identities into the daily lives of consumers via mobile apps and educational outreach in an effort to regain consumer trust (1). By 2018, the global pharmaceutical market is expected to be worth over $1.3 trillion; to corner their share of profits, established drug companies have to fight fierce competition from generic products, adhere to stringent government regulations, and sway a consumer base that is better informed than ever before. As a result, pharmaceutical companies are giving their brands personality traits by relying on physical attributes, practical functions, user imagery and usage contexts (2).

The shifting dynamic has prompted proponents of this marketing tactic to voice opinions that “an industry led by prescription drug personality branding may make health-related issues more approachable”—but Novus Executive Director Kent Runyon states that branding medications in an effort to evoke emotional value in the eyes of the consumer further encourages the acceptance of prescription drugs as an unavoidable aspect of life, which he deems to be a potential accomplice to widespread prescription drug use:

● 70 percent of Americans take prescription drugs, a number that has risen by 20 percentage points in five years, according to the Centers for Disease Control and Prevention (CDC) (3);

● Americans consume 80 percent of the world’s supply of painkillers (4), which some say can be attributed to the relentless advertising of brand-name prescription drugs that make it seem as though a pill can remedy nearly any illness or symptom (5).

Runyon has been a guest on CNBC and other major media outlets as an educational source on the influence of prescription drugs on the public. Runyon maintains that it is the responsibility of pharmaceutical companies, as well healthcare practitioners, to not only fully disclose the potential dangers to consumers, but to also ensure that such consumers fully comprehend the risks of using prescription medications.

“Marketing is intended to increase sales. Selling drugs is an economic advantage, but not necessarily in the best interest of the public,” stated Runyon. “We’ve yet to gain control of prescription substance abuse within the U.S.—in fact, RX substance abuse is arguably at its worst point in years,” said Runyon.

Because of the addictive nature of prescription drugs, Runyon advises the public to first consider natural remedies which, in many cases, can assuage common symptoms or discomfort. For those still considering prescription drug use, Runyon suggests having an in-depth conversation with a physician who can help determine the best course of action for each individual’s health.

Novus opened its doors with the purpose of fixing the detox process in order to ensure that anyone could overcome prescription drug addiction comfortably. The detox center handles the toughest of drug and alcohol cases, many of whom are rejected from other facilities as “too high a risk.”

Runyon advises those who are dependent on any abusive substance(s) to seek out safe, medically-supervised detox programs, and to use those employing integrated medicine that allows the detox process to be as comfortable as possible.

For more information on Novus Medical Detox’s addiction and detox programs, visit http://www.NovusDetox.com.

About Novus Medical Detox Center:

Novus Medical Detox Center offers safe, effective alcohol and drug treatment programs in a home-like residential setting. Located on 3.25 tree-lined acres in New Port Richey, Fla., Novus is licensed by the Florida Department of Children and Families as an inpatient medical detox facility. Novus is known for minimizing the discomfort of withdrawal from prescription medication, drugs or alcohol by creating a customized detox program for each patient, incorporating medication, natural supplements and fluid replenishment—putting the dignity and humanity back into drug detoxification. Patients have 24/7 medical supervision, including round-the-clock nursing care and access to a withdrawal specialist, and enjoy comfortable private or shared rooms with a telephone, television, DVD player and high-speed Internet access. For more information, visit http://www.novusdetox.com.

1. “Welcome to the New Face of Big Pharma.” Adweek.com. N.p., 29 Sept. 2013. Web. 15 Apr. 2014. adweek.com/news/advertising-branding/welcome-new-face-big-pharma-marketing-152767.

2. Taylor, Lynne. “How Big Pharma Is “humanising” Its Brands.” Pharmatimes.com. N.p., 5 Feb. 2014. Web. 15 Apr. 2014. pharmatimes.com/article/14-02-05/How_Big_Pharma_is_humanising_its_brands.aspx.

3. Markert, Jennifer. “Pills for Everything: The Power of American Pharmacy.” Curiousmatic.com. N.p., 11 July 2013. Web. 20 Mar. 2014. curiousmatic.com/pills-for-everything-the-power-of-american-pharmacy/.

4. Zennie, Michael. “Americans Consume EIGHTY Percent of the World’s Pain Pills as Prescription Drug Abuse Epidemic Explodes.” N.p., 10 May 2012. Web. 20 Mar. 2014. dailymail.co.uk/news/article-2142481/Americans-consume-80-percent-worlds-pain-pills-prescription-drug-abuse-epidemic-explodes.html.

5. “There’s a Pill for That: Drug Prescriptions in the U.S. Hit a Record High.” News.yahoo.com. Yahoo!, 14 Sept. 2012. Web. 20 Mar. 2014. news.yahoo.com/theres-pill-drug-prescriptions-u-hit-record-high-195404492.html.

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.